Stocks and Investing Stocks and Investing
Wed, April 15, 2020

Matthew Harrison Maintained (BGNE) at Buy with Decreased Target to $184 on, Apr 15th, 2020


Published on 2024-10-27 02:58:47 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "BeiGene, Ltd." (BGNE) at Buy with Decreased Target from $210 to $184 on, Apr 15th, 2020.

Matthew has made no other calls on BGNE in the last 4 months.



There are 2 other peers that have a rating on BGNE. Out of the 2 peers that are also analyzing BGNE, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Tyler Van Buren of "Piper Sandler" Downgraded from Buy to Hold on, Monday, December 16th, 2019


This is the rating of the analyst that currently disagrees with Matthew


  • Ziyi Chen of "Goldman Sachs" Initiated at Strong Buy and Held Target at $197 on, Tuesday, February 18th, 2020
Contributing Sources